The anti-oxidant capacity of tumour glycolysis

References

• Altenberg B, Greulich KO. 2004. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84:1014–1020.
   PubMed Web of Science ®Google Scholar
• Anghileri LJ. 1983. Warburg's cancer theory revisited: A fundamentally new approach. Archiv für Geschwulstforschung 53:1–8.
   PubMedGoogle Scholar
• Brand K. 1997. Aerobic glycolysis by proliferating cells: Protection against oxidative stress at the expense of energy yield. Journal of Bioenergetics and Biomembranes 29:355–364.
   PubMed Web of Science ®Google Scholar
• Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. 2001. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 51:349–353.
   PubMed Web of Science ®Google Scholar
• Brown JM, Wilson WR. 2004. Exploiting tumour hypoxia in cancer treatment. Nature Reviews Cancer 4:437–447.
   PubMed Web of Science ®Google Scholar
• Callot V, Galanaud D, Le FY, Confort-Gouny S, Ranjeva JP, Cozzone PJ. 2008. (1)H MR spectroscopy of human brain tumours: A practical approach. European Journal of Radiology 67:268–274.
   PubMed Web of Science ®Google Scholar
• Chang SM, Nelson S, Vandenberg S, Cha S, Prados M, Butowski N, McDermott M, Parsa AT, Aghi M, Clarke J, Berger M. 2009. Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. Journal of Neuro-Oncology 92:401–415.
   PubMedGoogle Scholar
• Dang CV. 2007. The interplay between MYC and HIF in the Warburg effect. In: Kroemer G, Mumberg D, Keun H, Riefke B, Steger-Hartmann T, Petersen, K, editors. Oncogenes meet metabolism, 1st edn, Berlin, Heidelberg: Springer. pp. 35–53.
   Google Scholar
• DeBerardinis RJ. 2008. Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genetics in Medicine 10:767–777.
   PubMed Web of Science ®Google Scholar
• Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY. 2004. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. The Journal of Biological Chemistry 279:22284–22293.
   PubMed Web of Science ®Google Scholar
• Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Mackensen A, Kunz-Schughart L, Andreesen R, Krause SW, Kreutz M. 2007. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:3812–3819.
   PubMed Web of Science ®Google Scholar
• Ganapathy V, Thangaraju M, Prasad PD. 2009. Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond. Pharmacology & Therapeutics 121:29–40.
   PubMed Web of Science ®Google Scholar
• Gottfried E, Kunz-Schughart LA, Ebner S, Mueller-Klieser W, Hoves S, Andreesen R, Mackensen A, Kreutz M. 2006. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107:2013–2021.
   PubMed Web of Science ®Google Scholar
• Grotius J, Dittfeld C, Huether M, Mueller-Klieser W, Baumann M, Kunz-Schughart L. 2009. Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitro. International Journal of Radiation Biology (in press).
   PubMedGoogle Scholar
• Groussard C, Morel I, Chevanne M, Monnier M, Cillard J, Delamarche A. 2000. Free radical scavenging and antioxidant effects of lactate ion: an in vitro study. Journal of Applied Physiology 89:169–175.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Gloe T, Pohl U. 2001. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. Journal of Cellular Physiology 188:33–44.
   PubMedGoogle Scholar
• Jeong JI, Lee YW, Kim YK. 2003. Chemical hypoxia-induced cell death in human glioma cells: role of reactive oxygen species, ATP depletion, mitochondrial damage and Ca2+. Neurochemical Research 28:1201–1211.
   PubMedGoogle Scholar
• Keul J, Keppler D, Doll E. 1967. Lactate-pyruvate ratio and its relation to oxygen pressure in arterial, coronarvenous and femoralvenous blood. Archives Internationales de Physiologie et de Biochimie 75:573–578.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Pitiakoudis M, Giatromanolaki A, Tsarouha A, Polychronidis A, Sivridis E, Simopoulos C. 2006. Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Science 97:1056–1060.
   PubMedGoogle Scholar
• Kroemer G, Pouyssegur J. 2008. Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell 13:472–482.
   PubMed Web of Science ®Google Scholar
• Larsen E, Reite K, Nesse G, Gran C, Seeberg E, Klungland A. 20-4-2006. Repair and mutagenesis at oxidized DNA lesions in the developing brain of wild-type and Ogg1−/− mice. Oncogene 25:2425–2432.
   PubMedGoogle Scholar
• Li X, Vigneron DB, Cha S, Graves EE, Crawford F, Chang SM, Nelson SJ. 2005. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. American Journal of Neuroradiology 26:760–769.
   PubMedGoogle Scholar
• Lin X, Zhang F, Bradbury CM, Kaushal A, Li L, Spitz DR, Aft RL, Gius D. 2003. 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Research 63:3413–3417.
   PubMed Web of Science ®Google Scholar
• Lu H, Forbes RA, Verma A. 2002. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. The Journal of Biological Chemistry 277:23111–23115.
   PubMed Web of Science ®Google Scholar
• Mitka M. 2005. Diabetic retinopathy mechanism probed. JAMA: The Journal of the American Medical Association 293:148–149.
   PubMedGoogle Scholar
• Mueller-Klieser W, Walenta S. 1993. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. The Histochemical Journal 25:407–420.
   PubMedGoogle Scholar
• O'Donnell-Tormey J, Nathan CF, Lanks K, DeBoer CJ, de la HJ. 1987. Secretion of pyruvate. An antioxidant defense of mammalian cells. The Journal of Experimental Medicine 165:500–514.
   PubMed Web of Science ®Google Scholar
• Quennet V, Yaromina A, Zips D, Rosner A, Walenta S, Baumann M, Mueller-Klieser W. 2006. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiotherapy and Oncology 81:130–135.
   PubMed Web of Science ®Google Scholar
• Raizer JJ, Koutcher JA, Abrey LE, Panageas KS, DeAngelis LM, Lis E, Xu S, Zakian KL. 2005. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. Journal of Neuro-Oncology 71:173–180.
   PubMed Web of Science ®Google Scholar
• Roslin M, Henriksson R, Bergstrom P, Ungerstedt U, Bergenheim AT. 2003. Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. Journal of Neuro-Oncology 61:151–160.
   PubMedGoogle Scholar
• Roudier E, Perrin A. 2009. Considering the role of pyruvate in tumor cells during hypoxia. Biochimica et Biophysica Acta DOI: 10.1016/j.bbcan.2009.02.003.
   PubMedGoogle Scholar
• Salahudeen AK, Clark EC, Nath KA. 1991. Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. The Journal of Clinical Investigation 88:1886–1893.
   PubMed Web of Science ®Google Scholar
• Sattler UG, Walenta S, Mueller-Klieser W. 2007. A bioluminescence technique for quantitative and structure-associated imaging of pyruvate. Laboratory Investigation 87:84–92.
   PubMedGoogle Scholar
• Sattler UGA, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, Yaromina A, Zips D, Walenta S, Baumann M, Mueller-Klieser W. 2009. Glycolytic metabolism and tumour response to fractionated irradiation. Radiotherapy and Oncology (submitted)
   PubMedGoogle Scholar
• Semenza GL. 2009. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Seminars in Cancer Biology 19:12–16.
   PubMed Web of Science ®Google Scholar
• Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. The Journal of Clinical Investigation 118:3930–3942.
   PubMed Web of Science ®Google Scholar
• Stubbs M, Veech RL, Griffiths JR. 1995. Tumor metabolism: The lessons of magnetic resonance spectroscopy. Advances In Enzyme Regulation 35:101–115.
   PubMedGoogle Scholar
• Tabatabaei P, Bergstrom P, Henriksson R, Bergenheim AT. 2008. Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. Journal of Neuro-Oncology 90:35–39.
   PubMedGoogle Scholar
• Toyooka M, Kimura H, Uematsu H, Kawamura Y, Takeuchi H, Itoh H. 2008. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation. Clinical Imaging 32:251–258.
   PubMedGoogle Scholar
• Walenta S, Chau T-V, Schroeder T, Lehr HA, Kunz-Schughart LA, Fuerst A, Mueller-Klieser W. 2003. Metabolic classification of human rectal adenocarcinomas: A novel guideline for clinical oncologists? Journal of Cancer Research and Clinical Oncology 129:321–326.
   PubMed Web of Science ®Google Scholar
• Walenta S, Mueller-Klieser WF. 2004. Lactate: Mirror and motor of tumor malignancy. Seminars in Radiation Rncology 14:267–274.
   PubMed Web of Science ®Google Scholar
• Walenta S, Schroeder T, Mueller-Klieser W. 2004. Lactate in solid malignant tumors: Potential basis of a metabolic classification in clinical oncology. Current Medicinal Chemistry 11:2195–2204.
   PubMed Web of Science ®Google Scholar
• Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK, Mueller-Klieser W. 2000. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Research 60:916–921.
   PubMed Web of Science ®Google Scholar
• Warburg O. 1929. Ist die aerobe Glykolyse spezifisch für die Tumoren? Biochemische Zeitschrift 204:482–483.
   Google Scholar
• Warburg O. 1956. On the origin of cancer cells. Science 123:309–314.
   PubMed Web of Science ®Google Scholar
• Warburg O, Poesener K, Negelein E. 1924. Über den Stoffwechsel der Carcinomzelle. Biochemische Zeitschrift 152:309–344.
   Google Scholar
• Xu M, See SJ, Ng WH, Arul E, Back MF, Yeo TT, Lim, CC. 2005. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 56:919–926.
   PubMed Web of Science ®Google Scholar
• Yaromina A, Quennet V, Zips D, Meyer S, Shakirin G, Walenta S, Mueller-Klieser W, Baumann M. 2009. Co-localization of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts. International Journal of Radiation Biology in press.
   Google Scholar
• Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh JA, Quennet V, Walenta S, Mueller-Klieser W, Baumann M. 2006. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiotherapy and Oncology 81:122–129.
   PubMed Web of Science ®Google Scholar
• Yeung SJ, Pan J, Lee MH. 2008. Roles of p53, MYC and HIF-1 in regulating glycolysis – the seventh hallmark of cancer. Cellular and Molecular Life Sciences 65:3981–3999.
   PubMed Web of Science ®Google Scholar